Chaudry; Imtiaz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chaudry; Imtiaz.The latest application filed is for "nebulizable compositions of quaternary ammonium muscarinic receptor antagonists".

Company Profile

0.21.23

Chaudry; Imtiaz - Napa CA US
Chaudry; Imtiaz - American Canyon CA
Chaudry; Imtiaz - Nazareth PA
Chaudry; Imtiaz - Denville NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nasal pharmaceutical formulations and methods of using the same Grant 9,808,471 - Chaudry November 7, 2	2017-11-07
Nebulizable Compositions Of Quaternary Ammonium Muscarinic Receptor Antagonists App 20170266113 - Chaudry; Imtiaz	2017-09-21
Formoterol/steroid bronchodilating compositions and methods of use thereof Grant 9,597,396 - Banerjee , et al. March 21, 2	2017-03-21
Inhalable formulations for treating pulmonary hypertension and methods of using same Grant 9,498,437 - Chaudry November 22, 2	2016-11-22
Formulations and methods for treating rhinosinusitis Grant 9,180,126 - Chaudry November 10, 2	2015-11-10
Formulations and methods for treating rhinosinusitis Grant 8,912,174 - Chaudry December 16, 2	2014-12-16
Formulations and methods for treating rhinosinusitis Grant 8,663,695 - Chaudry March 4, 2	2014-03-04
Formulations and methods for treating rhinosinusitis Grant 8,309,061 - Chaudry November 13, 2	2012-11-13
Formulations And Methods For Treating Rhinosinusitis App 20120237559 - Chaudry; Imtiaz	2012-09-20
Nasal pharmaceutical formulations and methods of using the same Grant 8,158,154 - Chaudry April 17, 2	2012-04-17
Formulations and methods for treating rhinosinusitis Grant 8,129,364 - Chaudry March 6, 2	2012-03-06
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease Grant 8,084,461 - Chaudry , et al. December 27, 2	2011-12-27
Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same App 20110265786 - Chaudry; Imtiaz	2011-11-03
Albuterol And Ipratropium Inhalation Solution, System, Kit And Method For Relieving Symptoms Of Chronic Obstructive Pulmonary Disease App 20110247613 - Chaudry; Imtiaz ; et al.	2011-10-13
Beclomethasone dipropionate monohydrate nasal pharmaceutical formulations and methods of using the same Grant 7,972,627 - Chaudry July 5, 2	2011-07-05
Fluticasone propionate nasal pharmaceutical formulations and methods of using same Grant 7,972,626 - Chaudry July 5, 2	2011-07-05
Nasal pharmaceutical formulations and methods of using the same Grant 7,811,606 - Chaudry October 12, 2	2010-10-12
Nasal Pharmaceutical Formulations And Methods Of Using The Same App 20080058295 - Chaudry; Imtiaz	2008-03-06
Formulations And Methods For Treating Rhinosinusitis App 20080058296 - Chaudry; Imtiaz	2008-03-06
Nasal Pharmaceutical Formulations And Methods Of Using The Same App 20080050442 - Chaudry; Imtiaz	2008-02-28
Inhalable formulations for treating pulmonary hypertension and methods of using same App 20060104913 - Chaudry; Imtiaz	2006-05-18
Nasal pharmaceutical formulations and methods of using the same App 20060051299 - Chaudry; Imtiaz	2006-03-09
Formulations and methods for treating rhinosinusitis App 20060051300 - Chaudry; Imtiaz	2006-03-09
Nasal pharmaceutical formulations and methods of using the same App 20060039871 - Chaudry; Imtiaz	2006-02-23
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease App 20050207985 - Chaudry, Imtiaz ; et al.	2005-09-22
Formulations and methods for treating rhinosinusitis App 20050180925 - Chaudry, Imtiaz	2005-08-18
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma App 20050175544 - Chaudry, Imtiaz ; et al.	2005-08-11
Inhalable formulations for treating pulmonary hypertension and methods of using same App 20040265238 - Chaudry, Imtiaz	2004-12-30
Nasal pharmaceutical formulations and methods of using the same App 20040208830 - Chaudry, Imtiaz	2004-10-21
Nasal pharmaceutical formulations and methods of using the same App 20040208831 - Chaudry, Imtiaz	2004-10-21
Formulations and methods for treating rhinosinusitis App 20040209852 - Chaudry, Imtiaz	2004-10-21
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma Grant 6,702,997 - Chaudry , et al. March 9, 2	2004-03-09
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease App 20030203930 - Chaudry, Imtiaz ; et al.	2003-10-30
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease Grant 6,632,842 - Chaudry , et al. October 14, 2	2003-10-14
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease App 20030191151 - Chaudry, Imtiaz ; et al.	2003-10-09
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease App 20030149007 - Chaudry, Imtiaz ; et al.	2003-08-07
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma App 20030140920 - Chaudry, Imtiaz ; et al.	2003-07-31
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma App 20030124063 - Chaudry, Imtiaz ; et al.	2003-07-03
Insoluble copper-alpha interferon complex Grant 4,871,538 - Yim , et al. October 3, 1	1989-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.